The moiety may also be a targeting moiety, an imaging moiety, a chelating moiety, a charged moiety, or a therapeutic moiety.

Advantageously, the further moiety is a directly or indirectly cytotoxic moiety or a readily detectable moiety.

This invention relates to a conjugate of a polymer moiety and an interferon- moiety, an erythropoietin moiety, or a growth hormone moiety

The traceable surfactant preferably includes a phosphate moiety, a phosphonate moiety, or a phosphinate moiety.

The binder portion is, in particular, an antibody portion.

First, the hydrocarbon feed is separated into a C5- cut, a C6-C7 cut, and a C8+ cut.

The donor moiety and the acceptor moiety exhibit fluorescence resonance energy transfer when the donor moiety is excited and the distance between the donor moiety and the acceptor moiety is small.

The binding moiety comprises at least one aryl moiety and an acidic moiety which is covalently attached to a phenyl portion of the aryl moiety or to a heteroatom of a heteroaryl portion of the aryl moiety.

Advantageously, moiety comprises a further, readily detectable moiety.

Agents comprise a detectable moiety bound to a photoreactive moiety.

The products from the hydrocarbon synthesis step typically include a C4-fraction, a C5-20 fraction, and a C20+ wax fraction.

A preferred embodiment of the monosaccharide moiety is a hexose moiety, more preferred is a glucose moiety, and most preferred is a glucose moiety which is bonded to the GalNAc-moiety by an α-1,4 glycosidic bond.

The surfactant preferably includes a sulfonate moiety or other sulfur-containing moiety.

This mineral fraction, in turn, is then fractionated from the hydrocarbonaceous fraction.

The chemical agents for the present invention comprising (a) an adenosine analog moiety or an adenosine moiety, and (b) an imaging moiety.